Lol, the poster? Abstract shows they still aren't reporting full top line data. Posters are certainly not more in depth than peer review. No results posted on FDA clinical website either, but no surprise there. Not even listing a P3 PDD trial on their 2022 list.
I know someone who talked with anavex IR 6+ months ago on PDD trial. Supposedly the rest of the results were "complicated". C'est la vie.
News 
Market Data 
Discover 
